Royal Biotech Government Tender Profile

With a substantial portfolio of 1948 government tender participations, Royal Biotech has demonstrated strategic engagement in India's public procurement landscape. This analysis provides insights into their bidding performance, tender success patterns, and competitive positioning in government contracts.

Proven L1 Bid Success with 449 Contract Wins

Royal Biotech has successfully secured 449 L1 positions in government tenders, demonstrating their strategic pricing approach and competitive bid strategy. With a win ratio of 23.0% across 1948 tender participations, they have established a reliable track record in government procurement. Their bidding performance also includes 0 L2 and 0 L3 rankings, showing consistent competitiveness in public sector contracts.

Notably, Royal Biotech has demonstrated capability in high-value government contracts, participating in 6 major procurement projects. This experience with premium government tenders indicates their capacity to handle significant public sector work and complex project requirements.

Financial Performance in Government Tenders

Royal Biotech has bid on contracts with a total value of ₹,82,09,38,150.0, successfully securing ₹,82,09,38,150.0 in government contract value. This represents a 100.0% conversion rate of bid value to won contracts, demonstrating their effectiveness in targeting and securing valuable public sector projects.

The company's average Earnest Money Deposit (EMD) of ₹,51,346.0 indicates their financial capacity to participate in substantial government tenders requiring significant bid security.